Bruker Corporation BRKR recently announced the launch of the neofleX Imaging Profiler for mass spectrometry-based tissue imaging at the 72nd ASMS meeting. The novel, high-performance MALDI-TOF/TOF ...

Brukers market-leading MALDI system - the first MALDI-TOF/TOF that adapts to your needs The rapifleX is the most advanced MALDI TOF/TOF system on the market today and it is also the most adaptable.

neofleX is a versatile, high-performance, and easy-to-use multiomics MSI system for biopharma, translational and clinical researchers neofleX Imaging Profiler MALDI-TOF/TOF with proprietary smartbeam ...

Innovative timsTOF platform combined with extreme MALDI PharmaPulse speed and robustness for unbiased, deep HTS and uHTS (ultra-high-throughput screening) Trapped Ion Mobility Spectrometry (TIMS): ...

Identification and confirmation of microbial isolates is crucial in the analysis workflow, providing decision-makers the information required to release or hold products. Despite the difficulties in ...

The rapifleX MALDI PharmaPulse (MPP) accelerates label-free hit finding in drug discovery: rapifleX MPP combines the unambiguousness of mass spectrometry with the required speed to comb through large ...